FIELD: medicine.
SUBSTANCE: invention concerns medicine, namely immunology, and can be used for prevention of recurrence and treatment of herpes virus infections. Method is implemented as follows. In remission period, synthetic dipeptide gamma-D-glutamyl-L-tryptophan is introduced intranasally in a dose 50-100 mcg daily within 7-10 days. In exacerbation period, synthetic dipeptide gamma-D-glutamyl-L-tryptophan is introduced intranasally in a dose 100 mcg daily within 10 days within integrated antiviral therapy involving preparations valaciclovir 500 mg orally 1 tablet twice a day - 5-10 days, penciclovir for external application on affected areas 3-4 times a day within 5-7 days.
EFFECT: invention enables reductions of acute period and prolonged recurrence of herpes virus infection due to normalisation of amount of T-helpers, T-suppressors, NK cells and their relations, intensified formation of endogenous interferon.
3 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING INFECTIONS INDUCED BY HERPES SIMPLEX VIRUSES TYPE I AND II, CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS | 2008 |
|
RU2391981C2 |
| METHOD OF TREATING SKIN AND MUCOSAL DISEASES CAUSED BY HERPES SIMPLEX VIRUSES TYPE 1 AND TYPE 2 | 2013 |
|
RU2530587C1 |
| METHOD OF TREATING RECURRENT GENITAL HERPES WITH CHRONIC FATIGUE SYMPTOMS | 2012 |
|
RU2492861C1 |
| METHOD OF TREATING AFFECTION OF VEGETATIVE PARASYMPATHETIC NODES OF HEAD OF HERPES-VIRUS ETIOLOGY | 2013 |
|
RU2538083C1 |
| CYTOKINE-CONTAINING COMPOSITION FOR TREATING VIRAL DISEASES | 2009 |
|
RU2447897C2 |
| IMMUNOCORRECTIVE AGENT FOR TREATING DISEASES OF VIRAL AETIOLOGY | 2007 |
|
RU2411039C2 |
| METHOD OF TREATING ACUTE GENITAL AND UROGENITAL INFECTIONS | 2010 |
|
RU2429847C1 |
| METHOD OF TREATMENT OF PATIENTS WITH HERPES VIRUS INFECTION USING IN VITRO ACTIVATED AUTOLOGICAL LYMPHOCYTES | 2022 |
|
RU2799141C2 |
| METHOD TO TREAT FEMALE RECURRENT GENITAL HERPES | 1999 |
|
RU2179849C2 |
| METHOD OF TREATMENT FOR GENITAL HERPES | 2007 |
|
RU2339377C1 |
